Dianabol 50 mg is an oral methandienone tablet manufactured by Dragon Pharma and dosed at 50 mg per tablet in a 100-tablet package.
Dianabol 50 mg contains methandienone, a synthetic anabolic-androgenic steroid that is orally active. Methandienone is a 17-alpha-alkylated testosterone derivative, a structural modification that allows it to survive first-pass metabolism through the liver and remain bioavailable when taken orally. It is one of the most historically significant anabolic steroids, having been developed in the late 1950s and used medically for a period before falling out of mainstream clinical favor.
In non-medical bodybuilding contexts, methandienone is commonly referenced as a mass-building oral used at the beginning of a cycle to accelerate gains in muscle size, strength, and body weight. Its aromatization to estrogen contributes to water retention and a rapid increase in scale weight, which is often perceived as rapid muscle gain. Methandienone has no current FDA approval for human use in the United States and is classified as a Schedule III controlled substance.
Methandienone is a 17-alpha-alkylated compound, which makes it orally active but also hepatotoxic. Liver function is a relevant monitoring consideration during use. It also suppresses endogenous testosterone production, and a post-cycle therapy protocol is commonly referenced in non-medical contexts. Non-medical use for physique or performance enhancement falls outside approved indications.
Methandienone is a 17-alpha-alkylated testosterone derivative characterized by strong anabolic activity, aromatization to estrogen, and a relatively short half-life requiring frequent daily dosing.
Methandienone is structurally derived from testosterone with modifications at the 17-alpha position for oral activity and at the 1,2 position to alter its anabolic-to-androgenic ratio. Its anabolic activity is substantially stronger than its androgenic activity, though it remains an aromatizable compound that converts to estrogen via the aromatase enzyme.
The aromatization of methandienone to methylestradiol is a defining characteristic that distinguishes it from non-aromatizing orals such as oxandrolone or stanozolol. This estrogenic activity contributes to water retention, increased blood pressure, and potential gynecomastia in susceptible individuals, but is also part of why methandienone produces rapid scale-weight gains.
Methandienone has a relatively short half-life of approximately 4–6 hours, which means it is typically dosed multiple times per day to maintain stable blood levels. This frequent dosing distinguishes it from longer-acting injectable compounds.
Methandienone's aromatization to estrogen and its short half-life define its practical profile: rapid onset of size and strength gains, accompanied by water retention and the need for frequent daily dosing.
Dragon Pharma offers several oral anabolic preparations with distinct profiles. Methandienone's aromatizing, mass-building character contrasts with Anavar 50, which is non-aromatizing and commonly referenced for lean muscle preservation during cutting phases. For users seeking a stronger oral with more pronounced androgenic effects but without aromatization, Winstrol 50 offers a stanozolol-based alternative. Dianabol 20 provides the same active substance at a lower strength for those requiring finer dose titration.
Published laboratory reports for Dianabol 50 mg are shown below with the test date, measured methandienone content, and percentage of the product's 50 mg label claim.
View Report
View Report
View Report
Laboratory results apply to the specific tested sample represented in each published report and should not be interpreted as a measurement of every tablet or production batch.
The information below is provided for educational reference only. Methandienone has no current FDA approval for human use in the United States and is a controlled substance. Non-medical use falls outside approved indications.
Methandienone dosing in non-medical bodybuilding contexts is typically expressed in milligrams per day and split across multiple administrations due to the compound's short half-life. Common reference ranges for men fall between 20–50 mg per day, with more experienced users sometimes referencing doses up to 100 mg per day. Dianabol 50 mg tablets are generally referenced as a higher-strength option suitable for experienced users or those requiring larger per-tablet doses.
| Use Case | Common Reference Range | Frequency |
|---|---|---|
| Beginner (non-medical) | 20–30 mg / day | Split into 2–3 doses |
| Intermediate (non-medical) | 30–50 mg / day | Split into 3–4 doses |
| Advanced (non-medical) | 50–100 mg / day | Split into 3–4 doses |
| Cycle duration (non-medical) | 4–6 weeks | Due to hepatotoxicity |
In non-medical bodybuilding contexts, methandienone is frequently referenced as a cycle starter or kickstart compound, used for the first 4–6 weeks of a longer injectable cycle to accelerate initial gains while longer-acting compounds build up in the system. It may be combined with injectable testosterone such as Testabol 400 or Deca 300 for mass-building phases. Stacking multiple oral 17-alpha-alkylated compounds is generally discouraged due to cumulative liver stress.
Because methandienone aromatizes, an aromatase inhibitor may be referenced in non-medical contexts to manage estrogenic side effects, though this should be based on individual response and bloodwork where possible.
Methandienone aromatizes to methylestradiol, which can contribute to water retention, elevated blood pressure, and gynecomastia in susceptible individuals. Aromatase inhibitors such as Arimidex are commonly referenced for managing these effects in non-medical contexts.
Blood pressure and lipid profile should be monitored during use, as methandienone can adversely affect both. Liver function is also a relevant monitoring consideration due to the 17-alpha-alkylated structure.
After completing a cycle with Dianabol 50 mg, post-cycle therapy is commonly recommended to help restore endogenous testosterone production and support hormonal recovery. Agents such as Clomid or Nolvadex are commonly referenced for this purpose.
PCT protocols vary based on cycle length, compounds used, and individual factors. Bloodwork and, where possible, medical guidance can help inform recovery strategy.
Dosing strategies, support compounds, and recovery protocols should be adjusted based on experience level and bloodwork where possible. The information above is for educational reference and does not constitute medical advice.
Methandienone is a Schedule III controlled substance in the United States with no current FDA approval for human use. It can affect liver function, lipid profiles, blood pressure, and endogenous hormone production.
Methandienone has no current FDA approval for human use in the United States. It is classified as a Schedule III controlled substance under the Anabolic Steroid Control Act. Anabolic steroids have not been shown to enhance athletic ability.
Methandienone is a 17-alpha-alkylated compound, a structural class associated with hepatotoxicity. Cholestatic hepatitis and jaundice have been reported with 17-alpha-alkylated androgens. Liver function should be monitored during use, and the compound should be discontinued if liver function abnormalities appear.
Methandienone has no approved human indication. Non-medical use falls outside approved indications and carries significant health risks including hepatotoxicity, cardiovascular strain, and endocrine suppression. Product strength and laboratory verification do not establish safety for human consumption.
Hepatotoxicity: As a 17-alpha-alkylated steroid, methandienone places stress on liver cells. Elevated liver enzymes, cholestasis, and in rare cases hepatic tumors have been reported with long-term use of 17-alpha-alkylated androgens.
Cardiovascular effects: Methandienone can decrease HDL cholesterol and increase LDL cholesterol, potentially accelerating atherosclerosis. Blood pressure elevation and fluid retention are also common, particularly with aromatization to estrogen.
Estrogenic effects: Aromatization to methylestradiol can cause gynecomastia, water retention, and elevated blood pressure. These effects are managed in non-medical contexts with aromatase inhibitors, though this should be based on individual response.
Androgenic effects: Acne, accelerated male-pattern hair loss, and increased body hair growth are possible. In women, virilization signs including voice deepening, hirsutism, and clitoromegaly may occur and can be irreversible.
Endocrine suppression: Methandienone suppresses endogenous testosterone production, leading to testicular atrophy, reduced libido, and potential fertility impairment.
Methandienone is contraindicated in known or suspected carcinoma of the prostate or male breast, carcinoma of the breast in females with hypercalcemia, pregnancy, nephrosis, and hypercalcemia. Caution is required in patients with a history of cardiovascular disease, liver disease, or risk factors for either.
Existing cardiovascular disease, liver dysfunction, abnormal blood counts, and other medical conditions should be discussed with a qualified healthcare professional before any consideration of anabolic steroid use.
There is no established monitoring protocol for non-medical methandienone use. For any human exposure, liver function tests, lipid panel, blood pressure, and hormonal status should be assessed by a qualified healthcare professional. Hemoglobin and hematocrit may also be relevant at higher doses.
Store in a cool, dry place away from direct light and moisture. Keep the product in its original packaging and out of the reach of children. This product is not for human consumption.
Dianabol 50 mg is supplied through the Dragon Pharma distribution chain and shipped in original manufacturer packaging with discreet, privacy-focused handling.
The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details. Products are supplied through the Dragon Pharma distribution chain.
To verify your Dianabol 50 mg product, cross-check the security features on the packaging against Dragon Pharma's official presentation. Batch-linked lab proof and original packaging help reinforce product legitimacy.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Proper storage conditions help preserve tablet integrity and overall product stability throughout shelf life.
Store in a cool, dry place away from excessive heat, moisture, and direct light. Maintaining stable conditions helps preserve the integrity of the tablets.
Keep the tablets in their original packaging until use. Do not use if the packaging appears compromised or if the tablets show signs of degradation such as discoloration or crumbling.
Keep out of reach of children. This product is not for human consumption.
Answers to common questions about Dianabol 50 mg, methandienone, oral bioavailability, dosing, and laboratory testing.
Dianabol 50 mg contains methandienone, an oral anabolic steroid. Methandienone has no current FDA approval for human use in the United States. In non-medical bodybuilding contexts, it is commonly referenced as a mass-building oral used at the beginning of a cycle to accelerate gains in muscle size, strength, and body weight. Such use falls outside approved indications.
Methandienone has a short half-life of approximately 4–6 hours, so it is typically referenced as being taken in divided doses 2–4 times per day in non-medical contexts. This frequent dosing helps maintain more stable blood levels compared to once-daily administration.
Methandienone is an anabolic-androgenic steroid that binds to androgen receptors and promotes nitrogen retention and protein synthesis. It is orally active due to its 17-alpha-alkylated structure and aromatizes to estrogen, which contributes to water retention and rapid scale-weight gains. It has no current FDA approval for human use.
Methandienone is known for rapid onset of effects. In non-medical contexts, users often report noticeable increases in scale weight and strength within the first 1–2 weeks of use. This rapid effect is partly attributable to water retention from aromatization rather than purely muscle tissue accrual.
There is no universally "best" oral anabolic steroid. Methandienone is distinguished by its rapid mass-building effects and aromatization. Other oral compounds such as Anavar 50 or Winstrol 50 have non-aromatizing profiles suited to different goals. The appropriate choice depends on individual goals and risk tolerance.
Methandienone is a testosterone-derived oral that aromatizes to estrogen, while oxandrolone is a DHT-derived oral that does not aromatize. This means methandienone is commonly associated with greater water retention and mass gains, while oxandrolone is referenced for lean muscle preservation. Dragon Pharma offers Anavar 50 as an oxandrolone-based alternative.
Methandienone aromatizes to estrogen and is used for mass-building, while stanozolol does not aromatize and is commonly referenced for lean muscle and strength without water retention. Dragon Pharma offers Winstrol 50 as a stanozolol-based alternative with a different application profile.
Methandienone has no approved human dose. In non-medical contexts, 50 mg per day represents the upper end of common reference ranges for men, with some experienced users referencing doses up to 100 mg per day. Dianabol 50 mg is labeled at 50 mg per tablet, making it a higher-strength option.
Dianabol 50 mg is labeled at 50 mg of methandienone per tablet. It is supplied in a 100-tablet package, giving 5,000 mg of total labeled methandienone content. Dragon Pharma also offers Dianabol 20 at a lower strength for finer dose titration.
Yes. Published laboratory reports for Dianabol 50 mg are available. The most recent report dated July 20, 2026 measured the product at 48.18 mg per tablet, equivalent to 96.36% of its 50 mg label claim. Complete reports can be viewed in the Lab Reports tab.
No. Methandienone has no current FDA approval for human use in the United States. It is classified as a Schedule III controlled substance under the Anabolic Steroid Control Act.